Scientists Find Gut Bacteria Behind Chronic Constipation

Millions of people suffering from chronic constipation may finally have an answer to why nothing seems to help. Scientists at Nagoya University in Japan have pinpointed two gut bacteria working together to cause the problem, and they've already shown how to stop them in early tests.

The culprits are Akkermansia muciniphila and Bacteroides thetaiotaomicron. These microbes team up to break down the protective mucus layer lining your colon, which normally keeps everything lubricated and moving smoothly.

Here's how the partnership works. Bacteroides removes protective sulfate groups from the mucus, like stripping away a shield. Then Akkermansia swoops in to digest the exposed mucus. When too much mucus disappears, stool becomes dry and hard, making it extremely difficult to pass.

The discovery helps explain why traditional laxatives often fail. Most treatments focus on speeding up gut movement, but if the root problem is missing mucus, those medications can't solve the underlying issue.

The research, published in Gut Microbes, revealed something particularly important for Parkinson's patients. People with Parkinson's have higher levels of these mucus-eating bacteria, and constipation often appears 20 to 30 years before their tremors begin. Doctors have always blamed nerve damage, but gut bacteria may be a significant contributor.

To test a potential solution, researchers genetically modified Bacteroides so it couldn't produce the sulfate-removing enzyme. When they introduced these altered bacteria into mice alongside Akkermansia, the mice didn't develop constipation at all. The protective mucus stayed intact.

Why This Inspires

This research represents a genuine breakthrough for people who've tried everything without relief. Chronic constipation affects quality of life in profound ways, limiting daily activities and causing constant discomfort.

The possibility of treatments that protect mucus rather than just push things along offers real hope. For Parkinson's patients especially, addressing constipation decades before movement symptoms appear could improve early quality of life significantly.

Lead researcher Tomonari Hamaguchi believes medications designed to block the bacterial enzyme could work in humans. The approach tackles the actual cause rather than just managing symptoms.

The team's work opens a completely new treatment pathway that millions of people with chronic, unexplained constipation have been waiting for.